In this study, our results showed that depletion of GADD45α by RNAi inhibited ESCC cells proliferation and promoted apoptosis, which suggested that GADD45α may be a novel and effective target for ESCC therapy. Here, GADD45A is linked to esophageal squamous cell carcinoma.